| 2008 JASN IMPACT FACTOR 7.505 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CLINICAL RESEARCH |

* Nephrology Service and
Gastroenterology Service, Walter Reed Army Medical Center, Washington, DC, and Uniformed Services University of the Health Sciences, Bethesda, Maryland
Correspondence: Dr. Frank P. Hurst, US Army, Walter Reed Army Medical Center, Washington, DC 20307. Phone: 202-782-6462; Fax: 202-782-0185; E-mail: frank.hurst{at}us.army.mil
Received for publication March 22, 2007. Accepted for publication August 10, 2007.
Oral sodium phosphate (OSP) is a commonly used purgative before colonoscopy. There have been numerous reports of acute phosphate nephropathy attributed to the use of OSP. This study evaluated the association between the use of OSP and acute kidney injury (AKI) in an observational, retrospective, cohort study. Of 9799 patients who underwent colonoscopy and had serum creatinine values recorded within 365 days before and after the procedure, AKI, defined as
50% increase in baseline serum creatinine, was identified in 114 (1.16%). After adjustment for significant covariates in a multiple logistic regression model, the use of OSP was associated with increased risk for AKI (odds ratio 2.35; 95% confidence interval 1.51 to 3.66; P < 0.001) with an adjusted number need to harm of 81. Age was also independently associated with AKI in this cohort; therefore, until larger, prospective studies define the population at risk for acute phosphate nephropathy, the use of polyethylene glycol-based purgatives should be considered for older patients and possibly for those with comorbid medical conditions.
Related Article
J. Am. Soc. Nephrol. 2007 18: 3020-3022.
This article has been cited by other articles:
![]() |
G. Lichtenstein Bowel preparations for colonoscopy: A review Am. J. Health Syst. Pharm., January 1, 2009; 66(1): 27 - 37. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Burtey, L. Daniel, H. Vacher-Coponat, B. Dussol, and Y. Berland Renal failure associated with colonoscopy--what is the link? NDT Plus, December 1, 2008; 1(6): 450 - 451. [Full Text] [PDF] |
||||
![]() |
K. C. Abbott, E. M. Bohen, and F. P. Hurst Oral Sodium Phosphate Drug Products and Renal Function Arch Intern Med, November 10, 2008; 168(20): 2285 - 2285. [Full Text] [PDF] |
||||
![]() |
E. C. Heher, S. O. Thier, H. Rennke, and B. D. Humphreys Adverse Renal and Metabolic Effects Associated with Oral Sodium Phosphate Bowel Preparation Clin. J. Am. Soc. Nephrol., September 1, 2008; 3(5): 1494 - 1503. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Connor, L. Sykes, I. S D Roberts, and C. E Weston Acute phosphate nephropathy after sodium phosphate preparations BMJ, July 17, 2008; 337(jul17_1): a182 - a182. [Full Text] |
||||
![]() |
S. M. Brunelli, J. D. Lewis, K. E. Lynch, M. M. Joffe, M. Gupta, S. M. Latif, M. G. Weiner, and H. I. Feldman Investigation of the association between oral sodium phosphate use and kidney injury NDT Plus, June 1, 2008; 1(3): 190 - 192. [Full Text] [PDF] |
||||
![]() |
N. Gibney, E. Hoste, E. A. Burdmann, T. Bunchman, V. Kher, R. Viswanathan, R. L. Mehta, and C. Ronco Timing of Initiation and Discontinuation of Renal Replacement Therapy in AKI: Unanswered Key Questions Clin. J. Am. Soc. Nephrol., May 1, 2008; 3(3): 876 - 880. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Markowitz, J. Radhakrishnan, and V. D. D'Agati Towards the Incidence of Acute Phosphate Nephropathy J. Am. Soc. Nephrol., December 1, 2007; 18(12): 3020 - 3022. [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2009 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673